SOAT1 and susceptibility to pneumonia measurement: Significant differences seen in the side effect profiles for patients treated with JAK/STAT inhibitors are increased risk of infections such as Herpes, cellulitis, pneumonia and urinary tract infection as well as increased risk for tuberculosis48.